The Women's Health Initiative has received the AACR Team Science Award for its pioneering research on hormone therapy and nutrition in cancer risk prevention. The program, which involved over 161,000 postmenopausal women, found significant increases in heart disease, stroke, and breast cancer risks with combination hormone therapy.
A phase I study of LOXO-101 demonstrated efficacy in reducing tumors in six patients with TRK fusion-positive cancers, including sarcoma, thyroid, and non-small cell lung. The study showed significant tumor regression in all six patients, with one patient experiencing a 17% tumor reduction.
Researchers at the University of Bath have developed a miniature fuel cell that can generate electricity from urine, offering an affordable and carbon-neutral way to produce power. The device has the potential to provide much-needed electricity to remote areas at low cost.
Professor Serge Ferrari has been recognized with the International Osteoporosis Foundation's 2016 Olof Johnell Science Award for his significant work in bone health, genetics of osteoporosis, and bone remodeling. He is a leading thought leader in the field, known for translating new research findings into improved patient care.
A new study found that the risk of a second major osteoporotic fracture increases by 4% for each year of age and is 41% higher in women than men. The risk of subsequent fractures decreases over time, but remains elevated throughout follow-up.
The IOF-ESCEO 2016 Pierre Meunier Young Scientist Awards were presented to Professors Elaine Dennison and Olivier Bruyère for their exceptional research on musculoskeletal ageing, osteoporosis, and osteoarthritis. The awards recognize their potential to become key opinion leaders in the field.
Researchers identified mechanisms that allow TRK-fusion lung cancer cells to evade targeted therapies. Specific genetic changes, including amino acid positions in TRK fusion genes, confer resistance to LOXO-101. This study's findings may have implications for other kinase-driven cancers treated with tyrosine kinase inhibitors.
Dr. Elias Hanna Saba, Chief Executive Director of the Palestinian Osteoporosis Prevention Society, was awarded the International Osteoporosis Foundation's Committee of National Societies Medal for his over 26 years of experience in bone and muscle health and patient education. The medal recognizes his dedication to expanding IOF's mess...
Professor Eugene McCloskey was recognized for his significant advancements in vertebral fracture definition, osteoporosis epidemiology, and non-invasive assessments of bone strength. He has contributed to the development of the FRAX tool and published over 250 peer-reviewed publications.
The International Cancer Genome Consortium (ICGC) has launched ICGCmed, a platform that links genomic data with clinical information to guide personalized cancer treatment. The initiative aims to accelerate the movement of genomic discoveries into the clinic.
The partnership will enable pharmaceutical companies to identify compounds most likely to succeed in human clinical trials, shortening the timeline to drug approval. Advanced lipidomic profiling analysis on tissues such as the liver will be made available, enhancing the depth and quality of scientific data.
Researchers at Ohio State University found that SPF30 sunscreens delayed melanoma onset in a mouse model by 80% when applied prior to UVB light exposure. The study suggests the potential of these sunscreens as effective melanoma-preventing agents.
Researchers developed a method to isolate circulating tumor cells from blood samples using gas microbubbles. The technique successfully isolated up to 80% of cancer cells in some cases, offering a rapid and inexpensive way to analyze these rare and fragile cells.